» Articles » PMID: 7039298

Hyperplastic, Preneoplastic and Neoplastic Lesions Found in 83 Human Pancreases

Overview
Specialty Pathology
Date 1982 Feb 1
PMID 7039298
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

A thorough histologic examination of the pancreas was performed on autopsy material from 83 military veterans aged 35-88 years. Hyperplastic, preneoplastic and neoplastic alterations were recorded by severity, multiplicity, location and age. From this material, two patients had clinically known primary, and three had secondary (metastatic), pancreatic cancer. The following occult malignant lesions were found: two early cancers (one adenocarcinoma and one adenosquamous cell carcinoma), one ductal carcinoma in situ and seven ductular carcinomas in situ. Among patients with ductular carcinoma in situ, three had pancreatic caner and the remaining four had cancers of other sites (ethmoid, ear, colon, prostate). One patient who was clinically diagnosed as having lung cancer with selective metastases to the pancreas was found to have pancreatic adenosquamous cell carcinoma with lung metastases. Hence, the incidence of neoplastic exocrine lesions was around 10%. In addition, hyperplasia of the ductal and ductular epithelium (in 57% and 39% of the patients, respectively), squamous cell metaplasia of the ductules (in 48% of the cases), as well as endocrine tumors (islet cell adenoma, 10%; mixed ductular-insular adenoma, 3%) were found. Most lesions occurred in the pancreatic head, a few in the tail. These data and other reports led to the conclusion that, first, the overall incidence of pancreatic cancer appears to be higher than previously reported. Malignant lesions seem to remain clinically occult, either because patients die of other diseases or because of the significantly long latency between premalignant lesions and clinically recognizable invasive cancer. Second, the ductular cells appear to be the progenitor cells of a variety of tumor types, including squamous cell cancer and islet cell tumors, as in the authors' experimental model.

Citing Articles

Familial pancreatic cancer: a long fruitful journey.

Brentnall T Fam Cancer. 2024; 23(3):217-220.

PMID: 38436765 DOI: 10.1007/s10689-024-00364-5.


Biomarkers of aging.

Bao H, Cao J, Chen M, Chen M, Chen W, Chen X Sci China Life Sci. 2023; 66(5):893-1066.

PMID: 37076725 PMC: 10115486. DOI: 10.1007/s11427-023-2305-0.


Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis.

Takayanagi T, Sekino Y, Kasuga N, Ishii K, Nagase H, Nakajima A Diagnostics (Basel). 2023; 13(5).

PMID: 36900107 PMC: 10000697. DOI: 10.3390/diagnostics13050963.


Adenosquamous carcinoma of the pancreas: two case reports and review of the literature.

Paramythiotis D, Kyriakidis F, Karlafti E, Didangelos T, Oikonomou I, Karakatsanis A J Med Case Rep. 2022; 16(1):395.

PMID: 36309754 PMC: 9618183. DOI: 10.1186/s13256-022-03610-5.


Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.

Braun R, Klinkhammer-Schalke M, Zeissig S, Kleihus van Tol K, Bolm L, Honselmann K Cancers (Basel). 2022; 14(16).

PMID: 36010939 PMC: 9406158. DOI: 10.3390/cancers14163946.